durvalumab,tremelimumab
AstraZeneca,Pfizer
['durva']
#esmo22 member is presenting the phase ii results of folfiri + durva vs folfiri+durva+trem in 2l treatment of patients with advanced #gej adenocarcinoma. which patients can benefit from the addition of ici in 2l? 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB